Form 4 Tracker
Bioventus Inc.
BVS

14 insider filings · Latest: Apr 10, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Mar 11, 2026Mar 13 9:26 PMMichelle Mcmurry-HeathDirector
Sale
12,000$8.79$105.4K44,997(D)

View →

Mar 11, 2026Mar 11 2:47 PMMcMurry-Heath Michelle
Proposed Sale
12,000$8.81$105.7K

View →

Dec 4, 2025Dec 4 6:54 PMNOHRA GUY P
Proposed Sale
10,000$7.57$75.7K

View →

Nov 7, 2025Nov 7 9:14 PMMcMurry-Heath Michelle
Proposed Sale
27,000$7.41$200.0K

View →

Apr 11, 2025Apr 11 9:39 PMD'Adamio Anthony
Proposed Sale
4,000$9.51$38.0K

View →

Mar 24, 2025Mar 24 8:50 PMSingleton Mark Leonard
Proposed Sale
12,000$9.80$117.6K

View →

Jan 13, 2025Jan 14 2:16 AMClaypoole Robert E
Proposed Sale
33,000$9.55$315.1K

View →

Dec 23, 2024Dec 23 10:37 PMSingleton Mark Leonard
Proposed Sale
19,000$11.15$211.8K

View →

Dec 23, 2024Dec 23 10:35 PMCHURCH KATRINA J
Proposed Sale
8,000$11.15$89.2K

View →

Dec 23, 2024Dec 23 10:34 PMD'Adamio Anthony
Proposed Sale
16,000$11.15$178.4K

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Feb 15, 2026Feb 18 11:28 PMAnthony D'AdamioSVP & General Counsel
Option Exercise
12,98025,960(D)

View →

← Previous

Page 2 of 2